4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-057641
EVP, Research & CSO acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-09-22 | Option exercise | +8,000 | $1.53 | $12,240 | 107,700 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-09-22 | Option exercise · Stock Option (Right to Buy) | −8,000 | 251,130 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…